Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001847903-25-000006
Filing Date
2025-01-16
Accepted
2025-01-16 16:16:01
Documents
2
Period of Report
2025-01-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1737062154.html 3  
1 FORM 3 wk-form3_1737062154.xml 3 1726
2 EX-24 poaskanes.txt EX-24 4884
  Complete submission text file 0001847903-25-000006.txt   8235
Mailing Address C/O CENTESSA PHARMACEUTICALS PLC 3RD FLOOR 1 ASHLEY ROAD, ALTRINCHAM CHESHIRE X0 WA14 2DT
Business Address
Kanes Stephen (Reporting) CIK: 0001612859 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40445 | Film No.: 25535874

Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Issuer) CIK: 0001847903 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)